Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
03/12/2014 | CN101759560B Manufacturing method and use of trans-3-substituted phenyl acrylic acid derivative |
03/12/2014 | CN101612362B Complex preparation for regulating lipid and preventing and curing heart cerebrovascular diseases and preparation method thereof |
03/12/2014 | CN101217952B Composition for preventing occurrence of cardiovascular event |
03/11/2014 | US8669293 Method and compositions for preventing hormone induced adverse effects |
03/11/2014 | US8669254 Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents |
03/11/2014 | US8669092 Urocortin-III and uses thereof |
03/11/2014 | US8669081 Compositions useful as inhibitors of protein kinases |
03/11/2014 | CA2784180C Seven-membered ring compound and pharmaceutical use therefor |
03/11/2014 | CA2581769C Methods of using chimeric coiled-coil molecule |
03/11/2014 | CA2573000C Composition containing statins and omega-3 fatty acids |
03/11/2014 | CA2488346C Methods and compositions for the repair and/or regeneration of damaged myocardium |
03/11/2014 | CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells |
03/06/2014 | WO2014036323A1 Method and composition for treating hyperglycemia |
03/06/2014 | WO2014035361A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF |
03/06/2014 | WO2014035289A1 A pharmaceutical composition for stimulation of angiogenesis |
03/06/2014 | WO2014034922A1 Peptide for inhibiting vascular endothelial growth factor receptor |
03/06/2014 | WO2014034842A1 Combination of sglt2 inhibitor and anti-hypertension drug |
03/06/2014 | WO2014034719A1 Quinoline derivative having tlr inhibitory activity |
03/06/2014 | WO2014033221A1 Otamixaban for use in the treatment of non-st elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting |
03/06/2014 | WO2014004902A3 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
03/06/2014 | WO2013158782A3 Methods and compositions for treating cardiac arrhythmias |
03/06/2014 | US20140066361 Peptides and use thereof in the inhibition of angiotensin converting enzyme |
03/06/2014 | DE102012017516A1 New 1-aryloxy-3-pyrrol-1-yl-propan-2-one derivatives are cytosolic phospholipase A2 inhibitors, useful for prophylactic or therapeutic treatment of diseases caused by increased activity of phospholipase A2, preferably e.g. pain and fever |
03/05/2014 | EP2703487A1 Peptide for inducing regeneration of tissue and use thereof |
03/05/2014 | EP2703481A1 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor |
03/05/2014 | EP2703392A1 5-membered ring aromatic heterocyclic derivative having npy y5 receptor antagonistic activity |
03/05/2014 | EP2702996A1 Anemia-ameliorating composition |
03/05/2014 | EP2702993A1 Macrocyclic lactone compounds and methods for their use |
03/05/2014 | EP2702990A1 Antiarrhythmic drug, atrial fibrillation inhibitor, model of sustained atrial fibrillation and method for producing same, and method for screening atrial fibrillation inhibitor |
03/05/2014 | EP2702987A1 Phosphodiesterase type III (PDE III) inhibitors or Ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy |
03/05/2014 | EP2702986A1 Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy |
03/05/2014 | EP2702069A2 Il4/il13 binding repeat proteins and uses |
03/05/2014 | EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists |
03/05/2014 | EP2702053A2 Novel rock inhibitors |
03/05/2014 | EP2702042A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators |
03/05/2014 | EP2702037A1 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease |
03/05/2014 | EP2702033A1 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease |
03/05/2014 | EP2701731A1 Intravascular delivery of nanoparticle compositions and uses thereof |
03/05/2014 | EP2701696A2 Impaired energy processing disorders and mitochondrial deficiency |
03/05/2014 | EP2701683A1 Administration of iloprost as aerosol bolus |
03/05/2014 | CN103619874A Soluble integrin [alpha]4 mutant |
03/05/2014 | CN103619845A Fluoroalkyl-substituted pyrazolopyridines and use thereof |
03/05/2014 | CN103619838A Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists |
03/05/2014 | CN103619834A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists |
03/05/2014 | CN103619817A Novel bicyclic nitrogen containing heteroaryl TGR5 receptor modulators |
03/05/2014 | CN103619339A Tablet containing limaprost and ss-cyclodextrin |
03/05/2014 | CN103619323A Administration of iloprost as aerosol bolus |
03/05/2014 | CN103614240A Production method of Abelmoschus manihot essential oil |
03/05/2014 | CN103613587A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor |
03/05/2014 | CN103613586A Optically sensitive pure S-(-)-arotinolol acid salt, preparation method and applications thereof |
03/05/2014 | CN103613574A Medical application of 2, 2-dimethyl thiochromanone compounds containing piperazine structures and analogues thereof |
03/05/2014 | CN103613527A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor |
03/05/2014 | CN103611167A Application of miR-106a in inhibiting expression and glucose uptake of glioma cell SLC2A3 |
03/05/2014 | CN103611159A Application of nitrosyl ruthenium coordination compound with 2-methyl-8-hydroxyquinoline as ligand |
03/05/2014 | CN103611149A Pentapeptide metabolite and application of pentapeptide metabolite in preparation of medicament for preventing and treating ischemic cerebrovascular diseases |
03/05/2014 | CN103611109A Traditional Chinese medicine preparation for treating anaphylactic purpura caused by deficiency of qi and blood |
03/05/2014 | CN103611092A Traditional Chinese medicine preparation for treating portal hypertension liver cirrhosis |
03/05/2014 | CN103611088A Medicine for treating coronary disease and preparation method thereof |
03/05/2014 | CN103611077A Traditional Chinese medicine composition for treating sub-health |
03/05/2014 | CN103611068A Pharmaceutical composition for treating arrhythmia |
03/05/2014 | CN103611066A Traditional Chinese medicine for treating hypertension accompanying with hyperlipidemia |
03/05/2014 | CN103611063A Traditional Chinese medicine formula for treating cardio-cerebro vascular diseases |
03/05/2014 | CN103611051A Traditional Chinese medicinal preparation for preventing and treating coronary heart disease and preparation method thereof |
03/05/2014 | CN103611043A Red ginseng and goji berry life-prolonging traditional Chinese medicinal preparation |
03/05/2014 | CN103611020A Medicament formula for external use for treating haemorrhoids |
03/05/2014 | CN103610983A Traditional Chinese medicine preparation for treating cerebral apoplexy |
03/05/2014 | CN103610965A Medicament for treating heart blood stasis type thoracic obstruction |
03/05/2014 | CN103610949A Traditional Chinese medicine preparation for effectively treating high blood pressure |
03/05/2014 | CN103610948A Traditional Chinese medicine composition for treating hypertension |
03/05/2014 | CN103610936A Chinese medicinal preparation for treating coronary heart disease and preparation method thereof |
03/05/2014 | CN103610916A Traditional Chinese medicine preparation for treating arteriosclerosis |
03/05/2014 | CN103610909A Medicinal composition for treating cervical vertigo |
03/05/2014 | CN103610899A Traditional Kazakhstan medicament composition for treating qi-ying deficiency type hypertension and preparation method thereof |
03/05/2014 | CN103610893A Traditional Chinese medicine for treating coronary disease |
03/05/2014 | CN103610890A Industrial preparation process of immature bitter orange, longstamen onion bulb and cassia twig decoction |
03/05/2014 | CN103610870A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
03/05/2014 | CN103610866A Traditional Chinese medicine for treating hypertension |
03/05/2014 | CN103610848A Traditional Chinese medicine for treating cerebral thrombosis |
03/05/2014 | CN103610846A External traditional Chinese medicine ointment for treating hypertension |
03/05/2014 | CN103610835A Medicament for treating fundus hemorrhage |
03/05/2014 | CN103610832A Mountain flower crystal oral preparation and preparation method thereof |
03/05/2014 | CN103610817A Anus lotion |
03/05/2014 | CN103610799A Preparation process of immature bitter orange, longstamen onion bulb and cassia twig decoction |
03/05/2014 | CN103610795A Method for preparing eucommia ulmoides step-down oral preparation |
03/05/2014 | CN103610786A Chinese medicinal composition for treating coronary heart disease and preparation method thereof |
03/05/2014 | CN103610772A Traditional Chinese medicine for treating cerebral thrombosis |
03/05/2014 | CN103610771A External traditional Chinese medicine preparation for treating peripheral vascular disease |
03/05/2014 | CN103610770A Foot-soaking traditional Chinese medicine composition for treating diabetic feet |
03/05/2014 | CN103610748A Preparation method of external preparation for treating haemorrhoids |
03/05/2014 | CN103610735A Chinese herbal medicine compound powder for external application for treating hypertension |
03/05/2014 | CN103610725A Extraction method of general flavone in chrysanthemum |
03/05/2014 | CN103610718A Plant slice containing total ginsenosides and preparation and preparation prepared from plant slice |
03/05/2014 | CN103610703A Medicine composition for treating cardiovascular and cerebrovascular diseases as well as preparation method and quality control method thereof |
03/05/2014 | CN103610697A Civetta and preparation method thereof |
03/05/2014 | CN103610696A Water-soluble calculus bovis factitius composition as well as preparation method and application thereof |
03/05/2014 | CN103610695A Calculus bovis factitius clathrate compound as well as preparation method and application thereof |
03/05/2014 | CN103610678A Application of Trigolutesins A in preparation of medicament for treating myocardial ischemia |
03/05/2014 | CN103610675A Application of jateorhizine in pharmacy |
03/05/2014 | CN103610674A Solid preparation containing micronized prasugrel |
03/05/2014 | CN103610673A Pharmaceutical composition |